![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Cobicistat (COBI) in HIV-Infected Patients
with Mild to Moderate Renal Impairment
|
|
|
Reported by Jules Levin
HIV Drug Therapy
November 2-6, 2014
Glasgow, UK
M Fisher1, C McDonald2, G Moyle3, C Martorell4, M Ramgopal5, F Laplante6,
J Curley7, H Graham7, C Tran-Muchowski7, Y Liu7, MS Rhee7, J Szwarcberg7
1Brighton & Sussex Medical School, Brighton, UK; 2Tarrant County Infectious Disease Associates, Fort Worth, TX US;
3Chelsea & Westminster Hospital, London, UK; 4The Research Institute, Springfield, MA, US; 5Midway Immunology and Research Center, Fort Pierce, FL, US;
6Clinique Medicale du Quartier Latin, Montreal, Canada; 7Gilead Sciences, Foster City, CA, US
![Glascow1.gif](../images/110714/110714-5/Glascow1.gif)
![Glascow2.gif](../images/110714/110714-5/Glascow2.gif)
![Glascow3.gif](../images/110714/110714-5/Glascow3.gif)
![Glascow4.gif](../images/110714/110714-5/Glascow4.gif)
![Glascow5.gif](../images/110714/110714-5/Glascow5.gif)
![Glascow6.gif](../images/110714/110714-5/Glascow6.gif)
![Glascow7.gif](../images/110714/110714-5/Glascow7.gif)
![Glascow8.gif](../images/110714/110714-5/Glascow8.gif)
![Glascow9.gif](../images/110714/110714-5/Glascow9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|